New York, Jan 15, 2026, 17:56 EST — After-hours
- Rocket Lab shares dropped 1.1% during regular trading and edged lower in after-hours trading
- KeyBanc downgraded its rating to “sector weight,” cautioning that the positive developments are largely reflected in current prices
- A director revealed share sales in an SEC filing, highlighting a planned transaction
Shares of Rocket Lab Corporation slipped Thursday following a downgrade from KeyBanc, halting a recent rally that had drawn attention to the space company’s valuation. The stock closed down 1.13% at $90.76 and later dipped another 0.53% to $90.28 in after-hours trading. (Investing)
The downgrade hits hard because Rocket Lab is now seen as a high-beta proxy for “space-and-defense” enthusiasm, with its shares acting like they depend on fresh catalysts. In that environment, one company’s pullback can spark rapid selling.
This follows a steep climb that leaves minimal margin for missteps, delays, or confusing guidance — issues investors tend to tolerate when prices are low but swiftly penalize as valuations rise.
KeyBanc analysts, led by Michael Leshock, downgraded Rocket Lab to “sector weight” from “overweight” in a note released late Wednesday. They questioned, “What more do you want?” arguing that recent wins and positive momentum are already priced in. (MarketWatch)
A separate note from KeyBanc making the rounds on trading desks said Rocket Lab’s multi-year growth drivers “have become realized” and are now largely priced in, though it still ranks the company among the better-quality players in the space sector. The firm’s “sector weight” rating is basically neutral—on par with peers. (TipRanks)
Insider moves caught the spotlight as Director Merline Saintil reported offloading 96,000 shares on Jan. 13 at $86.58, part of an exchange-fund contribution. The next day, she sold another 12,500 shares at $90 under a Rule 10b5-1 plan, according to a U.S. securities filing. (SEC)
Rocket Lab manufactures and launches its Electron rocket while selling spacecraft parts and satellite platforms. The company is also working on Neutron, a bigger reusable rocket aimed at expanding its mission range and boosting its government contracts.
The government angle remains central. In December, the Space Development Agency handed Rocket Lab a firm fixed-price deal worth up to $805 million to produce 18 missile warning and tracking satellites. This came through an “Other Transaction Authority,” a procurement method outside usual federal rules. Alongside Rocket Lab, Lockheed Martin, Northrop Grumman, and L3Harris Technologies also secured awards in the same program. (SDA)
Following Thursday’s pullback, investors are eyeing whether the selling pressure eases or intensifies in the next session. They’re also focused on whether contract work translates smoothly into revenue, and if Rocket Lab can maintain steady launch execution.
The stock’s sharp climb leaves scant margin for error. Any delays, botched launches, or cost overruns on fixed-price contracts could push investors to rethink a narrative built on confidence and rapid progress.
Traders are eyeing earnings next: MarketBeat has Rocket Lab’s next quarterly report penciled in for Feb. 26 after the close, though the company hasn’t officially confirmed. Updates on launch cadence, contract timing, and Neutron’s schedule will likely shape sentiment heading into March. (Marketbeat)
